Englander Institute for Precision Medicine

Publications

Found 785 results
Author Title Type [ Year(Asc)]
2023
Benedetti E, Liu EMinwei, Tang C, Kuo F, Buyukozkan M, Park T, Park J, Correa F, A Hakimi A, Intlekofer AM et al..  2023.  A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariation.. Nat Metab. 5(6):1029-1044.
Scarpa JR, Elemento O.  2023.  Multi-omic molecular profiling and network biology for precision anaesthesiology: a narrative review.. Br J Anaesth. 131(1):26-36.
Song W-M, Elmas A, Farias R, Xu P, Zhou X, Hopkins B, Huang K-L, Zhang B.  2023.  Multiscale protein networks systematically identify aberrant protein interactions and oncogenic regulators in seven cancer types.. J Hematol Oncol. 16(1):120.
Mlynarczyk C, Teater M, Pae J, Chin CR, Wang L, Arulraj T, Barisic D, Papin A, Hoehn KB, Kots E et al..  2023.   mutation yields supercompetitive B cells primed for malignant transformation.. Science. 379(6629):eabj7412.
Hussain M, Sternberg CN, Efstathiou E, Fizazi K, Shen Q, Lin X, Sugg J, Steinberg J, Noerby B, De Giorgi U et al..  2023.  Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial.. J Urol. 209(3):532-539.
Altorki NK, Walsh ZH, Melms JC, Port JL, Lee BE, Nasar A, Spinelli C, Caprio L, Rogava M, Ho P et al..  2023.  Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.. Nat Commun. 14(1):8435.
Bamias A, Merseburger A, Loriot Y, James N, Choy E, Castellano D, Lopez-Rios F, Calabrò F, Kramer M, de Velasco G et al..  2023.  New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors.. J Immunother Cancer. 11(1)
Barnes J, Brendel M, Gao VR, Rajendran S, Kim J, Li Q, Malmsten JE, Sierra JT, Zisimopoulos P, Sigaras A et al..  2023.  A non-invasive artificial intelligence approach for the prediction of human blastocyst ploidy: a retrospective model development and validation study.. Lancet Digit Health. 5(1):e28-e40.
Fornarini G, Rebuzzi SE, Buti S, Rescigno P, Merseburger A, Sternberg CN, De Giorgi U, Basso U, Maruzzo M, Giannatempo P et al..  2023.  A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score.. Minerva Urol Nephrol. 75(3):308-318.
Bhardwaj P, Iyengar NM, Zahid H, Carter KM, Byun DJun, Choi MHo, Sun Q, Savenkov O, Louka C, Liu C et al..  2023.  Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in .. Sci Transl Med. 15(684):eade1857.
Lauritsen J, Sauvé N, Tryakin A, Jiang DMaria, Huddart R, Heng DYC, Terbuch A, Winquist E, Chovanec M, Hentrich M et al..  2023.  Outcomes of relapsed clinical stage I versus de novo metastatic testicular cancer patients: an analysis of the IGCCCG Update database.. Br J Cancer. 129(11):1759-1765.
Vanpouille-Box C, Galluzzi L.  2023.  p53 regulates the mitochondrial immune checkpoint.. Trends Immunol. 44(4):245-247.
Li Y, Porta-Pardo E, Tokheim C, Bailey MH, Yaron TM, Stathias V, Geffen Y, Imbach KJ, Cao S, Anand S et al..  2023.  Pan-cancer proteogenomics connects oncogenic drivers to functional states.. Cell. 186(18):3921-3944.e25.
Rowdo FPMadorsky, Xiao G, Khramtsova GF, Nguyen J, Olopade OI, Martini R, Stonaker B, Boateng R, Oppong JK, Adjei EK et al..  2023.  Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.. bioRxiv.
Askari E, Moghadam SZarehparva, Wild D, Delpassand E, Baldari S, Nilica B, Hartrampf PE, Kong G, Grana CMaria, Walter MAlexander et al..  2023.  Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review.. J Nucl Med Technol. 51(1):22-25.
Borregales LD, Venkat S, Calderon LPosada, Lewicki P, Flynn T, Faltas BM, Molina AM, Golombos DM, O'Malley P, Scherr DS.  2023.  A Pilot Study on Hyperthermic Intraperitoneal Chemotherapy after Radical or Partial Cystectomy with Pelvic Lymph Node Dissection for High-risk Muscle-invasive Bladder Cancer.. Eur Urol. 84(6):604-606.
Hussain M, Sternberg CN, Efstathiou E, Fizazi K, Shen Q, Lin X, Sugg J, Steinberg J, Noerby B, De Giorgi U et al..  2023.  Plain language summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide? Future Oncol. 19(29):1953-1960.
Benedetti E, Chetnik K, Flynn T, Barbieri CE, Scherr DS, Loda M, Krumsiek J.  2023.  Plasma metabolomics profiling of 580 patients from an Early Detection Research Network prostate cancer cohort.. Sci Data. 10(1):830.
Kandola MS, Kulm S, Kim LK, Markowitz SM, Liu CF, Thomas G, Ip JE, Lerman BB, Elemento O, Cheung JW.  2023.  Population-Level Prevalence of Rare Variants Associated With Atrial Fibrillation and its Impact on Patient Outcomes.. JACC Clin Electrophysiol.
Charilaou P, Mohapatra S, Doukas S, Kohli M, Radadiya D, Devani K, Broder A, Elemento O, Lukin DJ, Battat R.  2023.  Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach.. J Gastroenterol Hepatol. 38(2):241-250.
Stangl-Kremser J, Sun M, Ho B, Thomas J, Nauseef JT, Osborne JR, Molina A, Sternberg CN, Nanus DM, Bander NH et al..  2023.  Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy.. Prostate. 83(14):1351-1357.
Parent P, Auclin E, Patrikidou A, Mezquita L, Chanzá NMartínez, Dumont C, Rodriguez-Vida A, Llacer C, Lozano R, Ratta R et al..  2023.  Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma.. Cancers (Basel). 15(4)
Guilbaud E, Spada S, Bloy N, Galassi C, Sato A, Jiménez-Cortegana C, Aretz A, Buqué A, Yamazaki T, Demaria S et al..  2023.  Quantitative assessment of mitophagy in irradiated cancer cells.. Methods Cell Biol. 174:93-111.
Sato A, Kraynak J, Marciscano AE, Galluzzi L.  2023.  Radiation therapy: An old dog learning new tricks.. Methods Cell Biol. 180:xv-xxv.
Sugita M, Yamazaki T, Alhomoud M, Martinet J, Latouche J-B, Golden E, Boyer O, Van Besien K, Formenti SC, Galluzzi L et al..  2023.  Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.. Cell Death Dis. 14(5):305.